The needle-free drug delivery devices market is poised to grow by USD 10.23 billion during 2020-2024, progressing at a CAGR of over 4% during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005486/en/
Technavio has announced its latest market research report titled Global Needle-free Drug Delivery Devices Market 2020-2024 (Graphic: Business Wire)
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
The report on the needle-free drug delivery devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by technological advances in needle-free drug delivery devices.
The needle-free drug delivery devices market analysis includes product segment and geography landscape. This study identifies the increasing government initiatives as one of the prime reasons driving the needle-free drug delivery devices market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The needle-free drug delivery devices market covers the following areas:
Needle-free Drug Delivery Devices Market Sizing
Needle-free Drug Delivery Devices Market Forecast
Needle-free Drug Delivery Devices Market Analysis
Antares Pharma Inc.
Dickinson and Co.
Enesi Pharma Ltd.
Inovio Pharmaceuticals Inc.
and Valeritas Holdings Inc.
Related Reports on Health Care Include:
Global Programmable Infusion Pumps Market: The global programmable infusion pumps market size has the potential to grow by USD 487.81 million during 2020-2024. The market’s growth momentum will accelerate throughout the forecast period because of the steady increase in year-over-year growth. To get extensive research insights: Click and Get FREE Sample Report in Minutes!
Global ENT Disorder Treatment Market: The ENT disorder treatment market size has the potential to grow by USD 1.32 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes!
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
2.2 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Value chain analysis
Market segmentation analysis
PART 04: MARKET SIZING
Market sizing 2019
Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
PART 06: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
Inhalers - Market size and forecast 2019-2024
Transdermal patches - Market size and forecast 2019-2024
Jet injectors - Market size and forecast 2019-2024
Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
Technological advances in needle-free drug delivery devices
Research and funding for development of needle-free drug delivery devices
Increasing government initiatives
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
Market positioning of vendors
Antares Pharma, Inc.
Becton, Dickinson and Co.
Enesi Pharma Ltd.
Inovio Pharmaceuticals Inc.
Valeritas Holdings Inc.
PART 14: APPENDIX
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005486/en/